Roland PS, Rutka JA (2004) Ototoxicity. BC Decker, Hamilton

Bokemeyer C et al (1998) Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer. Br J Cancer 77(8):1355–1362

Article  CAS  PubMed  PubMed Central  Google Scholar 

Frisina RD et al (2016) Comprehensive audiometric analysis of hearing impairment and tinnitus after cisplatin-based chemotherapy in survivors of adult-onset cancer. J Clin Oncol 34(23):2712–2720

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dillard LK et al (2022) Global burden of ototoxic hearing loss associated with platinum-based cancer treatment: a systematic review and meta-analysis. Cancer Epidemiol 79:102203

Article  PubMed  PubMed Central  Google Scholar 

Wake M et al (1994) Selective inner hair cell ototoxicity induced by carboplatin. Laryngoscope 104(4):488–493

Article  CAS  PubMed  Google Scholar 

Kujawa SG, Liberman MC (2009) Adding insult to injury: cochlear nerve degeneration after “temporary” noise-induced hearing loss. J Neurosci 29(45):14077–14085

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baguley DM, Prayuenyong P (2020) Looking beyond the audiogram in ototoxicity associated with platinum-based chemotherapy. Cancer Chemother Pharmacol 85(2):245–250

Article  CAS  PubMed  Google Scholar 

Sanchez VA et al (2024) Comprehensive audiologic analyses after cisplatin-based chemotherapy. JAMA Oncol 10(7):912–922

Article  PubMed  PubMed Central  Google Scholar 

Konrad-Martin D et al (2018) Applying US national guidelines for ototoxicity monitoring in adult patients: perspectives on patient populations, service gaps, barriers and solutions. Int J Audiol 57(sup4):S3–S18

Article  PubMed  Google Scholar 

Van Der Biest H et al (2025) Early markers of sensorineural hearing loss after platinum-based chemotherapy. Ear and Hearing. https://doi.org/10.1097/AUD.0000000000001714

Durrant JD, Campbell K, Fausti S, Guthrie O, Jacobson G, Lonsbury-Martin BL, Poling G (2009) American academy of audiology position statement and clinical practice guidelines: ototoxicity monitoring. http://www.audiology.org/resources/documentlibrary/Documents/OtoMonGuidelines

Prayuenyong P et al (2018) Vestibulotoxicity associated with platinum-based chemotherapy in survivors of cancer: a scoping review. Front Oncol 8:363

Article  PubMed  PubMed Central  Google Scholar 

Handelsman JA (2018) Vestibulotoxicity: strategies for clinical diagnosis and rehabilitation. Int J Audiol 57(sup4):S69–S77

Article  Google Scholar 

Lacour M et al (2016) Vestibular compensation: the neuro-otologist’s best friend. J Neurol 263:54–64

Article  Google Scholar 

Fleihan T et al (2024) Cisplatin vestibulotoxicity: a current review. Front Surg 11:1437468

Article  PubMed  PubMed Central  Google Scholar 

Hülse R et al (2022) Changes in vestibular function in patients with head-and-neck cancer undergoing chemoradiation. Ear Nose Throat J 101(6):379–385

Article  PubMed  Google Scholar 

Ehlert K et al (2025) Changes in vestibular and cochlear function following platinum-based chemotherapy: a preliminary report. Ear, Nose Throat J 104(6):NP337–NP348

Article  PubMed  Google Scholar 

Prayuenyong P et al (2021) Preferential cochleotoxicity of cisplatin. Front Neurosci 15:695268

Article  PubMed  PubMed Central  Google Scholar 

Takada N, Okuda H, Shibata H, Obara N, Mori K, Terazawa K et al (2025) Quantitative assessment of vestibular function by video head impulse test and vestibular‐evoked myogenic potential during cisplatin‐based Chemoradiation. Clin Otolaryngol 50(5):883–889

Theunissen EA et al (2015) Prediction of hearing loss due to cisplatin chemoradiotherapy. JAMA Otolaryngol-Head Neck Surg 141(9):810–815

Article  PubMed  Google Scholar 

American Speech-Language-Hearing Association (1994) Guidelines for the audiologic management of individuals receiving cochleotoxic drug therapy. ASHA 36 (Suppl 12):11–9

Fernandez K, Hoetink A, Konrad-Martin D, Berndtson D, Clark K, Dreisbach L, Geller JI, Goffi -Gomez MV, Grosnik A, Jamis C et al (2024) Roadmap to a global template for implementation of ototoxicity management for cancer treatment. Ear Hear 46:286–297

Dreisbach L et al (2017) Effects of oxaliplatin, carboplatin, and cisplatin across treatment on high-frequency objective and subjective auditory measures in adults. Perspect ASHA Spec Interest Groups 2(6):17–38

Article  Google Scholar 

Vasilkov V et al (2021) Enhancing the sensitivity of the envelope-following response for cochlear synaptopathy screening in humans: the role of stimulus envelope. Hear Res 400:108132

Article  PubMed  Google Scholar 

Portugal N, Poling GL, Dreisbach L (2024) Rethinking the clinical utility of distortion-product otoacoustic emission (DPOAE) signal-to-noise ratio. Int J Audiol 63(7):491–499

Article  PubMed  Google Scholar 

Coene M et al (2018) LiCoS: A new linguistically controlled sentences test to assess functional hearing performance. Folia Phoniatr Logop 70(2):90–99

Article  PubMed  PubMed Central  Google Scholar 

Keshishzadeh S, Verhulst S (2019) From derived-band envelope-following responses to individualized models of near-and supra-threshold hearing deficits. In: International Symposium on Auditory and Audiological Research, vol 7 (Nyborg), pp 13–20

Van Der Biest H et al (2023) Envelope following responses for hearing diagnosis: robustness and methodological considerations. J Acoust Soc Am 153(1):191–208

Article  PubMed  Google Scholar 

De Ridder D et al (2021) Tinnitus and tinnitus disorder: theoretical and operational definitions (an international multidisciplinary proposal). Prog Brain Res 260:1–25

PubMed  Google Scholar 

McCormack A et al (2016) A systematic review of the reporting of tinnitus prevalence and severity. Hear Res 337:70–79

Article  PubMed  Google Scholar 

Basheer JI et al (2025) Impact of cisplatin on hearing: analysis using PTA, high-frequency audiometry, DPOAE, and speech-in-noise test. OTO Open 9(1):e70097

Article  PubMed  PubMed Central  Google Scholar 

Knight KR et al (2007) Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions. J Clin Oncol 25(10):1190–1195

Article  CAS  PubMed  Google Scholar 

Laurell G, Bagger-Sjöbäck D (1991) Dose-dependent inner ear changes after iv administration of cisplatin. J Otolaryngol 20(3):158–167

CAS  PubMed  Google Scholar 

Zuur CL et al (2007) Risk factors of ototoxicity after cisplatin-based chemo-irradiation in patients with locally advanced head-and-neck cancer: a multivariate analysis. Int J Radiat Oncol* Biology* Physics. 68(5): p. 1320–1325

Skalleberg J et al (2020) The relationship between cisplatin-related and age-related hearing loss during an extended follow-up. Laryngoscope 130(9):E515–E521

Article  CAS  PubMed  Google Scholar 

Shahbazi M et al (2023) Comprehensive association analysis of speech recognition thresholds after cisplatin-based chemotherapy in survivors of adult-onset cancer. Cancer Med 12(3):2999–3012

Article  CAS  PubMed  Google Scholar 

Skalleberg J et al (2021) Speech perception 30 years after cisplatin-based chemotherapy in adults: limited clinical relevance of long-term ototoxicity? Acta Oncol 60(4):426–433

Article  CAS  PubMed  Google Scholar 

Keppler H et al (2010) The effects of aging on evoked otoacoustic emissions and efferent suppression of transient evoked otoacoustic emissions. Clin Neurophysiol 121(3):359–365

Article  PubMed  Google Scholar 

Lonsbury-Martin BL, Cutler WM, Martin GK (1991) Evidence for the influence of aging on distortion-product otoacoustic emissions in humans. J Acoust Soc Am 89(4):1749–1759

Article  CAS  PubMed  Google Scholar 

Dreisbach LE et al (2008) Influence of ultrahigh-frequency hearing thresholds on distortion-product otoacoustic emission levels at conventional frequencies. J Am Acad Audiol 19(04):325–336

Article  PubMed  Google Scholar 

Konrad-Martin D, Keefe DH (2005) Transient-evoked stimulus-frequency and distortion-product otoacoustic emissions in normal and impaired ears. J Acoust Soc Am 117(6):3799–3815

Article  PubMed